Phase I Study of Oxaliplatin (NSC 266046), Irinotecan, and Capecitabine in Patients With Solid Tumors.

Trial Profile

Phase I Study of Oxaliplatin (NSC 266046), Irinotecan, and Capecitabine in Patients With Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Mar 2010

At a glance

  • Drugs Capecitabine (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Jan 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov, last updated 30 Jan 2009.
    • 25 Oct 2007 Status changed from in progress to completed.
    • 18 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top